Jonathan Poole's Insider Trades & SAST Disclosures

Jonathan Poole's most recent trade in Acadia Pharmaceuticals Inc was a trade of 16,004 Director Stock Options (Right to Buy) done . Disclosure was reported to the exchange on May 29, 2026.

Share

Note

This is a custom search result for pattern Jonathan Poole.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Acadia Pharma Inc	Jonathan Poole	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 May 2026	16,004	16,004	-		-	Director Stock Options (Right to Buy)
Acadia Pharma Inc	Jonathan Poole	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 May 2026	9,311	9,311	-		-	Restricted Stock Units
Acadia Pharma Inc	Jonathan Poole	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 May 2026	2,010	0	-		-	Restricted Stock Units
Acadia Pharma Inc	Jonathan Poole	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 May 2026	2,010	2,010 (0%)	0%		-	Common Stock
Acadia Pharma Inc	Jonathan Poole	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2026	7,482	7,482	-		-	Director Stock Options (Right to Buy)
Acadia Pharma Inc	Jonathan Poole	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2026	4,218	4,218	-		-	Restricted Stock Units
Acadia Pharma Inc	Jonathan Poole	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2026	3,565	3,565	-		-	Director Stock Options (Right to Buy)
Acadia Pharma Inc	Jonathan Poole	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2026	2,010	2,010	-		-	Restricted Stock Units

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades